NCT04940000 Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
| NCT ID | NCT04940000 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Claudius Regaud |
| Condition | ORL Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 105 participants |
| Start Date | 2021-09-02 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 105 participants in total. It began in 2021-09-02 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years at study entry. 2. Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy. 3. Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). 4. Patient affiliated to a Social Security system in France. 5. Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure. Exclusion Criteria: 1. Pregnant or lactating women. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04940000 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ORL Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04940000 currently recruiting?
Yes, NCT04940000 is actively recruiting participants. Contact the research team at sarini.jerome@iuct-oncopole.fr for enrollment information.
Where is the NCT04940000 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT04940000 clinical trial?
NCT04940000 is sponsored by Institut Claudius Regaud. The trial plans to enroll 105 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.